Shared gene expression alterations in schizophrenia and bipolar disorder
- PMID: 18191109
- PMCID: PMC3098561
- DOI: 10.1016/j.biopsych.2007.11.010
Shared gene expression alterations in schizophrenia and bipolar disorder
Abstract
Background: Schizophrenia and bipolar disorder together affect approximately 2.5% of the world population, and their etiologies are thought to involve multiple genetic variants and environmental influences. The analysis of gene expression patterns in brain may provide a characteristic signature for each disorder.
Methods: RNA samples from the dorsolateral prefrontal cortex (Brodmann area 46) consisting of individuals with schizophrenia (SZ), bipolar disorder (BPD), and control subjects were tested on the Codelink Human 20K Bioarray platform. Selected transcripts were validated by quantitative real-time polymerase chain reaction (PCR). The strong effects of age, gender, and pH in the analysis of differential gene expression were controlled by analysis of covariance (ANCOVA). Criteria for differential gene expression were 1) a gene was significantly dysregulated in both BPD and SZ compared with control subjects and 2) significant in ANCOVA analysis with samples that have a pH above the median of the sample.
Results: A list of 78 candidate genes passed these two criteria in BPD and SZ and was overrepresented for functional categories of nervous system development, immune system development and response, and cell death. Five dysregulated genes were confirmed with quantitative Q-PCR in both BPD and SZ. Three genes were highly enriched in brain expression (AGXT2L1, SLC1A2, and TU3A). The distribution of AGXT2L1 expression in control subjects versus BPD and SZ was highly significant (Fisher's Exact Test, p < 10(-06)).
Conclusions: These results suggest a partially shared molecular profile for both disorders and offer a window into discovery of common pathophysiology that might lead to core treatments.
Figures
Similar articles
-
Gene expression analysis of bipolar disorder reveals downregulation of the ubiquitin cycle and alterations in synaptic genes.Mol Psychiatry. 2006 Oct;11(10):965-78. doi: 10.1038/sj.mp.4001875. Epub 2006 Aug 8. Mol Psychiatry. 2006. PMID: 16894394
-
Molecular evidence for mitochondrial dysfunction in bipolar disorder.Arch Gen Psychiatry. 2004 Mar;61(3):300-8. doi: 10.1001/archpsyc.61.3.300. Arch Gen Psychiatry. 2004. PMID: 14993118
-
Gene expression profiling in Brodmann's area 46 from subjects with schizophrenia.Aust N Z J Psychiatry. 2007 Apr;41(4):308-20. doi: 10.1080/00048670701213245. Aust N Z J Psychiatry. 2007. PMID: 17464717
-
Meta-analysis of MTHFR gene variants in schizophrenia, bipolar disorder and unipolar depressive disorder: evidence for a common genetic vulnerability?Brain Behav Immun. 2011 Nov;25(8):1530-43. doi: 10.1016/j.bbi.2010.12.006. Epub 2010 Dec 24. Brain Behav Immun. 2011. PMID: 21185933 Review.
-
Evidence for shared susceptibility in bipolar disorder and schizophrenia.Am J Med Genet C Semin Med Genet. 2003 Nov 15;123C(1):59-64. doi: 10.1002/ajmg.c.20014. Am J Med Genet C Semin Med Genet. 2003. PMID: 14601037 Review.
Cited by
-
Social stress increases expression of hemoglobin genes in mouse prefrontal cortex.BMC Neurosci. 2014 Dec 4;15:130. doi: 10.1186/s12868-014-0130-6. BMC Neurosci. 2014. PMID: 25472829 Free PMC article.
-
Dysregulation of circRNA expression in the peripheral blood of individuals with schizophrenia and bipolar disorder.J Mol Med (Berl). 2021 Jul;99(7):981-991. doi: 10.1007/s00109-021-02070-6. Epub 2021 Mar 29. J Mol Med (Berl). 2021. PMID: 33782720
-
Identification of a Bipolar Disorder Vulnerable Gene CHDH at 3p21.1.Mol Neurobiol. 2017 Sep;54(7):5166-5176. doi: 10.1007/s12035-016-0041-x. Epub 2016 Aug 25. Mol Neurobiol. 2017. PMID: 27562178
-
Hepatocyte nuclear factor 4 alpha is a key factor related to depression and physiological homeostasis in the mouse brain.PLoS One. 2015 Mar 16;10(3):e0119021. doi: 10.1371/journal.pone.0119021. eCollection 2015. PLoS One. 2015. PMID: 25774879 Free PMC article.
-
Molecular profile of dissociative drug ketamine in relation to its rapid antidepressant action.BMC Genomics. 2016 May 17;17:362. doi: 10.1186/s12864-016-2713-3. BMC Genomics. 2016. PMID: 27188165 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical